|
RUNDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.109580E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.519000E-01 |
| Normal-vs-Stage2 |
1.979820E-01 |
| Normal-vs-Stage3 |
4.623500E-02 |
| Normal-vs-Stage4 |
4.340000E-01 |
| Stage1-vs-Stage2 |
5.252000E-01 |
| Stage1-vs-Stage3 |
2.384800E-01 |
| Stage1-vs-Stage4 |
6.296000E-01 |
| Stage2-vs-Stage3 |
7.234800E-01 |
| Stage2-vs-Stage4 |
9.880000E-01 |
| Stage3-vs-Stage4 |
8.015000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.026000E-01 |
| Normal-vs-AfricanAmerican |
6.999700E-02 |
| Normal-vs-Asian |
2.536000E-01 |
| Caucasian-vs-AfricanAmerican |
4.369600E-01 |
| Caucasian-vs-Asian |
8.673800E-01 |
| AfricanAmerican-vs-Asian |
9.368600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.352500E-02 |
| Normal-vs-Female |
7.277000E-01 |
| Male-vs-Female |
3.289800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.389790E-01 |
| Normal-vs-Extreme_Weight |
7.793800E-02 |
| Normal-vs-Obese |
2.125800E-01 |
| Normal-vs-Extreme_Obese |
9.705000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.523600E-01 |
| Normal_Weight-vs-Obese |
5.702800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.054800E-01 |
| Extreme_Weight-vs-Obese |
6.317200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.158800E-01 |
| Obese-vs-Extreme_Obese |
6.252600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.286800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.100200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.262240E-02 |
| Normal-vs-Age(81-100Yrs) |
4.655700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.616000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.166800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.450400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.625700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.065900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.707430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.521000E-01 |
| Normal-VS-Type2 PRCC |
1.301620E-02 |
| Normal-VS-KIRP CIMP |
9.65680000000191E-05 |
| Normal-VS-Unclassified PRCC |
5.922400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.016050E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.624400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.525400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.465200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.404200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.017400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.019400E-03 |
| Normal-vs-N1 |
4.103200E-01 |
| Normal-vs-N2 |
2.108300E-02 |
| N0-vs-N1 |
4.039600E-01 |
| N0-vs-N2 |
7.100400E-01 |
| N1-vs-N2 |
5.510800E-01 |
|
|
